Prevalence, sociodemography, and quality of life of older versus younger patients with irritable bowel syndrome: a population-based study.

Digestive Diseases and Sciences
Anil MinochaWilliam Chad Wigington

Abstract

We studied the prevalence as well as the sociodemographic characteristics and QOL of older adults (> 50 years) with irritable bowel syndrome (IBS) among the population at large and compared it to their younger counterparts'. We hypothesized that IBS is less prevalent among older persons and they suffer poorer QOL compared to younger IBS patients. A total of 1000 adults from nine sites, including a medical center, churches, and a blood bank in our metropolitan area (670 African Americans, 320 Caucasians, and 10 others), completed self-administered questionnaires providing sociodemographic information and details regarding bowel habits and associated symptoms for diagnosing the IBS based on Rome II criteria. QOL was assessed by the SF-12 questionnaire. The study database was divided into two groups, younger (< 50 years) and older (> or = 50 years). The two age groups were similar with respect to gender and household income. Ninety-five of the 1000 participants had IBS, giving a total sample prevalence of 9.5% (< 50 years, 9.9%, vs > or = 50 years, 7.6%). The prevalence of IBS was similar in the two groups irrespective of race, sex, marital status, size of household, location of residence (rural versus urban), level of educational...Continue Reading

References

Sep 11, 1975·The New England Journal of Medicine·R B LasserM D Levitt
Jul 1, 1992·Journal of Gerontology·E A O'KeefeA R Zinsmeister
Jan 11, 1992·BMJ : British Medical Journal·R Jones, S Lydeard
Nov 1, 1990·Mayo Clinic Proceedings·N J TalleyL J Melton
Aug 1, 1990·Gastroenterology·R S Sandler
Oct 15, 1989·Annals of Internal Medicine·N J TalleyA R Zinsmeister
Mar 1, 1989·Gut·C A EdwardsN W Read
Jul 1, 1995·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·E A O'KeefeS J Jacobsen
May 1, 1995·Digestive Diseases and Sciences·I O OlubuyideA A Fasanmade
Jul 1, 1994·The Journal of Infection·M W McKendrick, N W Read
Jul 1, 1994·Gastroenterology·E A Mayer, G F Gebhart
Sep 1, 1993·Digestive Diseases and Sciences·A P WestonP B Miner
Feb 26, 1999·BMJ : British Medical Journal·L A Rodríguez, A Ruigómez
Sep 20, 2000·Mayo Clinic Proceedings·G R LockeL J Melton
Mar 14, 2001·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·E Corazziari
Apr 4, 2001·Alimentary Pharmacology & Therapeutics·S ZarM J Benson
Apr 30, 2002·Best Practice & Research. Clinical Gastroenterology·Greg Bennett, Nicholas J Talley
May 29, 2002·Alimentary Pharmacology & Therapeutics·H B El-SeragD Bjorkman
Aug 23, 2002·The American Journal of Gastroenterology·Yuri A SaitoG Richard Locke
Mar 19, 2003·Alimentary Pharmacology & Therapeutics·A P S HunginF Mearin
Apr 22, 2003·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·Feng Xiao LiLloyd R Sutherland
Apr 29, 2004·Alimentary Pharmacology & Therapeutics·G R LockeN J Talley
May 7, 2004·The American Journal of Gastroenterology·Kok-Ann GweeDamian J C Png
Mar 25, 2005·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·A D SperberA Fich
Oct 7, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·William Chad WigingtonAnil Minocha

❮ Previous
Next ❯

Citations

Jul 21, 2009·Current Gastroenterology Reports·Brennan M R Spiegel
Dec 12, 2012·Current Opinion in Endocrinology, Diabetes, and Obesity·Michael D Gershon
Mar 9, 2007·Postgraduate Medical Journal·Nick PowellChristopher J Corrigan
Jan 1, 2010·Clinical and Experimental Gastroenterology·Eugene J Burbige
Nov 26, 2010·Journal of Neurogastroenterology and Motility·Full-Young ChangTseng-Shing Chen
Mar 4, 2011·Journal of Neurogastroenterology and Motility·Govind K MakhariaAnand Krishnan
Mar 4, 2009·Digestive Diseases and Sciences·Angèle P M KerckhoffsWillem Renooij
Oct 3, 2014·Journal of Neurogastroenterology and Motility·Natalya IorioFrank K Friedenberg
Jun 4, 2016·Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates·Ozge TosunEmel Ahishali
Apr 3, 2018·Journal of Neurogastroenterology and Motility·Ashkan FarhadiLaurie Keefer
Aug 23, 2008·Journal of Clinical Gastroenterology·Enrique ReyManuel Diaz-Rubio
Dec 31, 2009·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Silke SteinbachWolfgang Huber
Aug 1, 2015·Health and Quality of Life Outcomes·Vilde Lehne MichalsenPer G Farup
Sep 10, 2014·Alimentary Pharmacology & Therapeutics·C CanavanT Card
Sep 19, 2014·World Journal of Gastroenterology : WJG·Rosa L S Soares
Oct 2, 2014·Alimentary Pharmacology & Therapeutics·O OlénA Bergström
Apr 11, 2019·Arquivos de neuro-psiquiatria·Zeynep Tugba OzanLevent Ertugrul Inan
Feb 19, 2009·The American Journal of Gastroenterology·Anthony J LemboFrancis H Creed
May 16, 2013·Advances in Nutrition·Virginia M QuickDianne Neumark-Sztainer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.